Faculty Disclosures
|
No disclosure on file
|
| Karen L. Furie, MD |
The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS. |
| David Chiu, MD |
Dr. Chiu has nothing to disclose. |
| Wengui Yu, MD, PhD |
Dr. Yu has nothing to disclose. |
| Joseph L. Schindler, MD |
Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care. |
| Lauren H. Sansing, MD |
Dr. Sansing has nothing to disclose. |
| Bradford B. Thompson, MD |
Dr. Thompson has nothing to disclose. |
| Samrina Hanif, MD |
Dr. Hanif has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova . |
| Latha Ganti, MD, MS, MBA, FACEP |
Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care. |
| Emily J. Gilmore, MD |
Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH. |
| Kevin N. Sheth, MD, FAAN |
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| W. T. Kimberly, MD, PhD |
Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |
| Linda C. Wendell, MD, FAAN |
Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple. |
| Vivek Misra, MD |
Dr. Misra has nothing to disclose. |
| Peter Chang |
No disclosure on file
|
| Ashkan Shoamanesh, MD |
Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer AG. Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo . Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier Inc.. Dr. Shoamanesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurodiem.ca. The institution of Dr. Shoamanesh has received research support from Servier Canada Inc.. The institution of Dr. Shoamanesh has received research support from Daiichi Sankyo Ltd.. The institution of Dr. Shoamanesh has received research support from Bayer AG. The institution of Dr. Shoamanesh has received research support from Bristol-Myers Squibb. The institution of Dr. Shoamanesh has received research support from Octapharma Canada . |
| Tiffany Chang, MD |
Dr. Chang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League. |
| Hooman Kamel, MD |
Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim. |
| Nils Petersen, MD |
The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH. |
| Justin M. Nolte, MD |
Dr. Nolte has nothing to disclose. |
| Paul B. Ferguson, MD, FAAN |
Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. |
| Adam S. Jasne, MD |
Dr. Jasne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
| Santosh B. Murthy, MD |
Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS. |
| Shyam S. Rao, MD |
No disclosure on file
|
| John Liang, MD |
Dr. Liang has nothing to disclose. |
| Michael Reznik, MD |
Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS. |
| Richa Sharma, MD |
Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care. |
| Ali Mahta, MD |
Dr. Mahta has nothing to disclose. |
| Farhaan S. Vahidy, MBBS, PhD |
Dr. Vahidy has nothing to disclose. |
| Kevin Gobeske, MD |
Dr. Gobeske has nothing to disclose. |
| Christoph Stretz, MD, FAAN |
The institution of Dr. Stretz has received research support from American Heart Association. The institution of Dr. Stretz has received research support from Duke University Medical Center/NIH. The institution of Dr. Stretz has received research support from University of Cincinnati/NINDS. |
| Brian Mac Grory, MB BCh BAO |
An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association. |
| Rachel Beekman, MD |
Dr. Beekman has nothing to disclose. |
| Guido J. Falcone, MD |
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA. |
| Aman Deep, MD |
Dr. Deep has nothing to disclose. |
| Stacy C. Brown, MD |
Dr. Brown has nothing to disclose. |
| Fnu Abhi Pandhi, MD |
No disclosure on file
|
| Muhammad F. Ishfaq, MD |
Dr. Ishfaq has nothing to disclose. |
| Charles D. McCane |
Mr. McCane has nothing to disclose. |
| Jill T. Shah |
No disclosure on file
|
| Christopher P. Kellner, MD |
Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID. |
| Audrey Leasure |
Ms. Leasure has nothing to disclose. |
| Miryam Alkayyali, MD |
Dr. Alkayyali has nothing to disclose. |
| Masaki Nagamine, MD |
Dr. Nagamine has nothing to disclose. |
| Harsh Patel, MBBS |
No disclosure on file
|
| Reza Bavarsad Shahripour, MD |
Dr. Bavarsad Shahripour has nothing to disclose. |
| Rajeel Imran, MD |
Dr. Imran has nothing to disclose. |
| Destiny L. Hooper |
No disclosure on file
|
| Salman Assad, MD, MBBS |
Dr. Assad has nothing to disclose. |
| Nishath Naseem, MD |
Dr. Naseem has nothing to disclose. |
| Tej Stead |
No disclosure on file
|
| Ana Hossein Zadeh Maleki, MD |
Dr. Hossein Zadeh Maleki has nothing to disclose. |
| Bradley Cahn |
Mr. Cahn has nothing to disclose. |
| Lindsey R. Kuohn, MD |
Dr. Kuohn has nothing to disclose. |
| Matthew Yuen |
Mr. Yuen has nothing to disclose. |
| Mercy H. Mazurek |
Miss Mazurek has nothing to disclose. |
| Kevin N. Vanent |
Mr. Vanent has nothing to disclose. |
| Charles Wira |
Charles Wira has nothing to disclose. |
| Sam Payabvash |
Sam Payabvash has nothing to disclose. |
| Gordon Sze |
Gordon Sze has nothing to disclose. |
| Charles Matouk |
Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis. |
| Scott Moody |
No disclosure on file
|
| Tracy E Madsen |
No disclosure on file
|
| Matthew Rosen |
Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeepSpin. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chipiron. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synex Medical. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nanalysis. Matthew Rosen has stock in Hyperfine. Matthew Rosen has stock in Q Bio. Matthew Rosen has stock in Vizma Life Sciences. Matthew Rosen has stock in Intact Data Services. The institution of Matthew Rosen has received research support from Imagion. Matthew Rosen has received intellectual property interests from a discovery or technology relating to health care. |